Scarica l'app Stockscreener
19.78
3.04%
-0.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Precedente Chiudi:
$20.40
Aprire:
$20.38
Volume 24 ore:
3.56M
Relative Volume:
2.43
Capitalizzazione di mercato:
$2.42B
Reddito:
$460.48M
Utile/perdita netta:
$142.80M
Rapporto P/E:
16.76
EPS:
1.18
Flusso di cassa netto:
$221.79M
1 W Prestazione:
-0.95%
1M Prestazione:
-2.32%
6M Prestazione:
-12.48%
1 anno Prestazione:
-7.35%
Intervallo 1D:
$19.75
$20.38
Intervallo di 1 settimana:
$19.66
$20.42
Portata 52W:
$19.15
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Nome
Catalyst Pharmaceuticals Inc
Settore
Industria
Telefono
(305) 529-2522
Indirizzo
355 ALHAMBRA CIRCLE, CORAL GABLES
Confronta CPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
19.78 | 2.50B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-03-14 | Iniziato | Citigroup | Buy |
| 2024-03-07 | Iniziato | BofA Securities | Buy |
| 2023-12-21 | Iniziato | Oppenheimer | Outperform |
| 2022-08-24 | Downgrade | ROTH Capital | Buy → Neutral |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Ripresa | Piper Jaffray | Overweight |
| 2016-10-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | Reiterato | ROTH Capital | Buy |
| 2014-09-16 | Reiterato | ROTH Capital | Buy |
| 2014-09-15 | Reiterato | H.C. Wainwright | Buy |
| 2013-10-21 | Reiterato | Aegis Capital | Buy |
| 2013-09-24 | Iniziato | Maxim Group | Buy |
| 2013-09-06 | Reiterato | Aegis Capital | Buy |
| 2013-04-18 | Iniziato | Aegis Capital | Buy |
| 2012-08-27 | Aggiornamento | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | Aggiornamento | Merriman | Sell → Neutral |
| 2009-05-29 | Downgrade | Hapoalim | Neutral → Underperform |
| 2009-05-29 | Downgrade | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | Iniziato | Merriman Curhan Ford | Buy |
| 2007-11-28 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | Iniziato | Stifel Nicolaus | Buy |
| 2007-01-05 | Iniziato | First Albany | Buy |
Mostra tutto
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
Downgrade Watch: Does Catalyst Pharmaceuticals Inc align with a passive investing strategyBreakout Watch & Verified Momentum Watchlists - khodrobank.com
Risk Analysis: What is the next catalyst for Petros Pharmaceuticals Inc2025 Biggest Moves & High Conviction Trade Alerts - khodrobank.com
Richard P Slaughter Associates Inc Sells 54,614 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals, Inc. $CPRX Stake Increased by Wesbanco Bank Inc. - MarketBeat
IPO Launch: Is Catalyst Pharmaceuticals Inc likely to announce a buybackWeekly Risk Report & Safe Swing Trade Setups - khodrobank.com
Swedbank AB Acquires Shares of 616,132 Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Loss Report: How does Catalyst Pharmaceuticals Inc. perform in inflationary periods2025 Momentum Check & Real-Time Buy Signal Alerts - khodrobank.com
Sell Signal: Is Catalyst Pharmaceuticals Inc likely to announce a buybackPrice Action & Long-Term Investment Growth Plans - khodrobank.com
First Week of November 21st Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
Catalyst Pharmaceuticals, Inc. $CPRX Stock Holdings Boosted by Redhawk Wealth Advisors Inc. - MarketBeat
Strs Ohio Takes Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Woodline Partners LP Has $5.01 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Aug Fed Impact: What is the next catalyst for CASI Pharmaceuticals IncEarnings Growth Report & Reliable Breakout Stock Forecasts - khodrobank.com
Buyback Watch: What is Catalyst Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Key Highlights & Community Consensus Picks - خودرو بانک
Aug PreEarnings: Can Catalyst Pharmaceuticals Inc stock outperform in a bear market2025 AllTime Highs & Real-Time Chart Pattern Alerts - khodrobank.com
AQR Capital Management LLC Sells 31,501 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Rally Mode: Is Catalyst Pharmaceuticals Inc a top pick in the sectorEarnings Growth Report & Free Fast Entry Momentum Trade Alerts - khodrobank.com
What is the next catalyst for CASI Pharmaceuticals IncMarket Trend Review & Technical Pattern Recognition Alerts - خودرو بانک
Chart Watch: Is Catalyst Pharmaceuticals Inc currently under institutional pressureJuly 2025 Action & Daily Profit Focused Screening - khodrobank.com
Ideas Watch: Will Catalyst Pharmaceuticals Inc benefit from government policyWeekly Risk Report & Stepwise Trade Execution Plans - khodrobank.com
Fred Alger Management LLC Buys Shares of 51,402 Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Insider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of Stock - MarketBeat
Is Despegarcom Corp a cyclical or defensive stockJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - خودرو بانک
Signal Recap: Should I trade or invest in Catalyst Pharmaceuticals IncGold Moves & Weekly Top Performers Watchlists - خودرو بانک
Technical Analysis: How is Catalyst Pharmaceuticals Inc. managing supply chain issues2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک
Catalyst Pharmaceutical (CPRX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Visualizing Catalyst Pharmaceuticals Inc. stock with heatmaps2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Top chart patterns to watch in Catalyst Pharmaceuticals Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Jacobs Levy Equity Management Inc. Sells 406,554 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Advisors Asset Management Inc. Has $4.34 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
21,083 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Purchased by Nomura Holdings Inc. - MarketBeat
Catalyst Pharmaceuticals, Inc. $CPRX Shares Purchased by Clark Capital Management Group Inc. - MarketBeat
New Vernon Capital Holdings II LLC Raises Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Is Catalyst Pharmaceuticals Inc.’s growth already priced inMarket Movement Recap & Long-Term Safe Investment Plans - Lancaster City Council
Is Catalyst Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Macro Impact & Low Risk High Win Rate Stock Picks - Lancaster City Council
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - MSN
Is Catalyst Pharmaceuticals Inc. impacted by rising ratesIndex Update & Verified Momentum Stock Alerts - 뉴스영
State of Wyoming Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Published on: 2025-09-07 06:18:36 - 뉴스영
Catalyst Pharmaceuticals Inc Azioni (CPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):